Indication
COVID-19 vaccination
COVID-19 vaccination refers to active immunization indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Read more about COVID-19 vaccination
14 drugs 3 manufacturers
Drugs that treat it
Common COVID-19 vaccination therapies.
SPIKEVAX 2026-2027 (6M-11Y) (COVID vaccine 2026-2027 (6 months-11 years)(Moderna)/PF)
COMIRNATY 2026-2027 (12Y UP) (COVID vaccine 2026-2027 (12 yrs up) (Pfizer)/PF)
COMIRNATY 2026-2027(5-11Y) (COVID vacc 2026-2027 (5-11 years) (Pfizer)/PF)
NUVAXOVID 2026-2027 (COVID vaccine 2026-2027 (12 yrs up)/adjuvant-Matrix/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCOVID-19 vaccination refers to active immunization indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The target condition primarily compromises the respiratory system, though it can induce multisystem disease ranging from mild upper respiratory symptoms to severe acute respiratory distress syndrome, hyperinflammation, thromboembolism, and multiorgan failure.
Vaccination is indicated across broad populations, particularly individuals at elevated risk of severe outcomes such as older adults, immunocompromised individuals, and those with underlying chronic comorbidities.
It functions by eliciting pathogen-specific humoral and cell-mediated immune responses, thereby significantly decreasing the risk of symptomatic infection, hospitalization, critical illness, and death.
- fda.gov
COVID-19 vaccination refers to active immunization indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Vaccination is indicated across broad populations, particularly individuals at elevated risk of severe outcomes such as older adults, immunocompromised individuals, and those with underlying chronic comorbidities
- nih.gov
COVID-19 vaccination refers to active immunization indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) The target condition primarily compromises the respiratory system, though it can induce multisystem disease ranging from mild upper respiratory symptoms to severe acute respiratory distress syndrome, hyperinflammation, thromboembolism, and multiorgan failure
- merckmanuals.com
The target condition primarily compromises the respiratory system, though it can induce multisystem disease ranging from mild upper respiratory symptoms to severe acute respiratory distress syndrome, hyperinflammation, thromboembolism, and multiorgan failure
- cdc.gov
Vaccination is indicated across broad populations, particularly individuals at elevated risk of severe outcomes such as older adults, immunocompromised individuals, and those with underlying chronic comorbidities
- mayoclinic.org
It functions by eliciting pathogen-specific humoral and cell-mediated immune responses, thereby significantly decreasing the risk of symptomatic infection, hospitalization, critical illness, and death
- cdc.gov
It functions by eliciting pathogen-specific humoral and cell-mediated immune responses, thereby significantly decreasing the risk of symptomatic infection, hospitalization, critical illness, and death
Personalize your experience
Follow COVID-19 vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.